Custom skin cancer aftercare report study
Part of Cancer, Skin clinical trials.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a type of skin cancer that is considered low-risk
- You are between 18 and 80 years old
- You have no personal history of melanoma
- You have less than 100 moles on your body
- You have had no more than 1 basal cell carcinoma (BCC) and no more than 1 squamous cell carcinoma (SCC), with the SCC more than 5 years ago
- You have not had an organ transplant and do not have a known genetic condition that increases skin cancer risk
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving you personalized genetic feedback about your skin cancer risk can help you protect your skin. You'll fill out a questionnaire, give a saliva sample, and receive results about a gene called MC1R that affects your risk.
This trial tests a new educational program to help people learn how to check their own skin for signs of skin cancer. It aims to make early detection easier, and you can join regardless of whether you have had skin cancer before.
This study asks people who had skin cancer surgery about how they feel about their appearance, their scar healing, and their quality of life. It may help doctors understand what outcomes matter most to patients after skin cancer treatment.
This early trial tests whether adding vitamin A and niacinamide (a form of vitamin B3) can help people with a history of certain skin cancers reduce new disease. It is designed for adults with specific prior skin cancer or skin lesion treatment patterns.
This study tests a personalized cell therapy called TIL (tumor-infiltrating lymphocytes) for people with advanced skin cancers that have not responded to immunotherapy. Doctors take your tumor cells, grow immune cells from them, and then infuse them back to fight the cancer.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
Hear when a new Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.